The company is continuing its due diligence and discussions pertaining to the possible licensing deal with Puri Blood, as well as other acquisition opportunities. In addition, the company is in the process of engaging a PCAOB audit firm to complete a two year audit of the company as part of an effort to file registration statement with the SEC. Mr. Mailander further commented "with the Company's June 30th fiscal year end approaching next week, I'm more optimistic than ever that the company is poised to do great things with the foundation we've managed to build."
News 
Market Data 
Discover 
AI
